Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METIMMOX
NCT03388190Phase 2Completed
- Start
- May 2018
- Primary completion
- Mar 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in colorectal cancer (CRC). Started May 2018; status: completed.
02
Drugs
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03388190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388190.